Thiopental sodium
Pentothal (thiopental sodium) is a small molecule pharmaceutical. Thiopental sodium was first approved as Pentothal on 1982-01-01. It is used to treat intracranial hypertension in the USA. It is known to target potassium voltage-gated channel subfamily C member 4.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
|---|---|
| nervous system diseases | D009422 |
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Thiopental sodium
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| PENTOTHAL | Abbott Biotherapeutics | N-011679 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| intracranial hypertension | EFO_1000992 | D019586 | — |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
18 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Infertility | D007246 | EFO_0000545 | — | — | — | 1 | — | 1 | |
| Coronary artery disease | D003324 | I25.1 | — | — | — | 1 | — | 1 | |
| Heart valve diseases | D006349 | EFO_0009551 | I08 | — | — | — | 1 | — | 1 |
| Postoperative nausea and vomiting | D020250 | EFO_0004888 | — | — | — | 1 | — | 1 | |
| Anesthesia | D000758 | — | — | — | 1 | — | 1 | ||
| Healthy volunteers/patients | — | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Depression | D003863 | F33.9 | — | — | 1 | — | 1 | 2 | |
| Septic shock | D012772 | A48.3 | — | — | 1 | — | — | 1 | |
| Traumatic brain injuries | D000070642 | S06 | — | — | 1 | — | — | 1 | |
| Status epilepticus | D013226 | EFO_0008526 | G41 | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Esthetics | D004954 | — | 1 | — | — | — | 1 | ||
| Strabismus | D013285 | HP_0000486 | H50.2 | — | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Memory disorders | D008569 | 1 | — | — | — | — | 1 | ||
| Amnesia | D000647 | EFO_1001454 | F44.0 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 1 | 1 |
| Phobic disorders | D010698 | EFO_1001908 | F40 | — | — | — | — | 1 | 1 |
| Alcoholism | D000437 | EFO_0003829 | F10.1 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | THIOPENTAL SODIUM |
| INN | thiopental sodium |
| Description | Sodium thiopental, also known as Sodium Pentothal (a trademark of Abbott Laboratories), thiopental, thiopentone, or Trapanal (also a trademark), is a rapid-onset short-acting barbiturate general anesthetic. It is the thiobarbiturate analog of pentobarbital, and an analog of thiobarbital. Sodium thiopental was a core medicine in the World Health Organization's List of Essential Medicines, but was supplanted by propofol. Despite this, thiopental is listed as an acceptable alternative to propofol, depending on local availability and cost of these agents. It was previously the first of three drugs administered during most lethal injections in the United States, but the US manufacturer Hospira stopped manufacturing the drug in 2011 and the European Union banned the export of the drug for this purpose. Although thiopental abuse carries a dependency risk, its recreational use is rare.
|
| Classification | Small molecule |
| Drug class | Barbiturate |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | CCCC(C)C1(CC)C(=O)[N-]C(=S)NC1=O.[Na+] |
Identifiers
| PDB | — |
| CAS-ID | 71-73-8 |
| RxCUI | — |
| ChEMBL ID | CHEMBL738 |
| ChEBI ID | 9561 |
| PubChem CID | 3000714 |
| DrugBank | DB00599 |
| UNII ID | 49Y44QZL70 (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
KCNC4
KCNC4
Organism
Homo sapiens
Gene name
KCNC4
Gene synonyms
C1orf30
NCBI Gene ID
Protein name
potassium voltage-gated channel subfamily C member 4
Protein synonyms
K+ channel subunit, KSHIIIC, potassium channel, voltage gated Shaw related subfamily C, member 4, potassium voltage-gated channel, Shaw-related subfamily, member 4, Voltage-gated potassium channel subunit Kv3.4
Uniprot ID
Mouse ortholog
Kcnc4 (99738)
potassium voltage-gated channel subfamily C member 4 (Q8R1C0)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 6,133 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
678 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more